3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting clinical scrutiny due to initial information suggesting unique physiological characteristics. Present research demonstrate that 3-HPC may possess independent impacts on the nervous structure, possibly playi